KAYLA SIMPSON: Open Payments
NPI 1790126613 · HARRISBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$295 in 14 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $28 · 2025 $295
Food & beverage: $295
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $103 |
| Janssen Biotech, Inc. | 2 | $48 |
| Phathom Pharmaceuticals, Inc. | 2 | $33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $28 |
| Novo Nordisk Inc | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
Products named: RINVOQ, TREMFYA, SKYRIZI, VOQUEZNA, XIFAXAN, Wegovy, DUPIXENT, IQIRVO.
Industry payments across PA — which companies pay providers there.
